STELLARS CAPITAL Buys 5% of Harvard Apparatus Regenerative Tech
Ticker: HRGN · Form: SC 13D · Filed: Sep 26, 2024 · CIK: 1563665
| Field | Detail |
|---|---|
| Company | Harvard Apparatus Regenerative Technology, Inc. (HRGN) |
| Form Type | SC 13D |
| Filed Date | Sep 26, 2024 |
| Risk Level | medium |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0.01, $2.5, $2.00 |
| Sentiment | neutral |
Sentiment: neutral
Topics: significant-stake, investment, schedule-13d
Related Tickers: HRGN
TL;DR
**STELLARS CAPITAL just bought 5% of HARVARD APPARATUS REGENERATIVE TECHNOLOGY, INC. (HRGN) for investment.**
AI Summary
On September 26, 2024, STELLARS CAPITAL PRIVATE I Ltd filed a Schedule 13D revealing it acquired 1,000,000 shares of Harvard Apparatus Regenerative Technology, Inc. common stock. This acquisition represents 5.0% of the outstanding shares, making STELLARS CAPITAL a significant beneficial owner. The filing indicates the shares were acquired for investment purposes.
Why It Matters
This filing signals a new significant investor in Harvard Apparatus Regenerative Technology, Inc., potentially influencing future corporate strategy or stock performance.
Risk Assessment
Risk Level: medium — The filing indicates a new significant shareholder, which could lead to changes in company direction or increased stock volatility.
Key Numbers
- 1,000,000 — Shares Acquired (Represents 5.0% of outstanding shares)
- 5.0% — Ownership Stake (Indicates significant beneficial ownership)
Key Players & Entities
- STELLARS CAPITAL PRIVATE I Ltd (company) — Filing entity
- Harvard Apparatus Regenerative Technology, Inc. (company) — Subject company
- Mao Zhang (person) — Contact person for filing entity
- 1,000,000 shares (dollar_amount) — Number of shares acquired
- 5.0% (dollar_amount) — Percentage of outstanding shares acquired
FAQ
Who is STELLARS CAPITAL PRIVATE I Ltd?
STELLARS CAPITAL PRIVATE I Ltd is the entity filing the Schedule 13D, indicating it has acquired a significant stake in Harvard Apparatus Regenerative Technology, Inc.
What is the purpose of this acquisition?
The filing states the shares were acquired for investment purposes.
When was this stake acquired or reported?
The filing was made on September 26, 2024, with the date as of change also being September 26, 2024.
What was the previous name of Harvard Apparatus Regenerative Technology, Inc.?
The company was formerly known as Biostage, Inc. until March 31, 2016.
What is the business address of Harvard Apparatus Regenerative Technology, Inc.?
The business address is 84 October Hill Road, Suite 11, Holliston, MA 01746.
Filing Stats: 1,183 words · 5 min read · ~4 pages · Grade level 10.5 · Accepted 2024-09-26 06:04:55
Key Financial Figures
- $0.01 — Inc. (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securiti
- $2.5 — r of the Issuer for a purchase price of $2.5 per share. On July 31, 2024, Stellars
- $2.00 — Common Stock with an exercise price of $2.00 per share, and exercised such warrants
Filing Documents
- formsc13d.htm (SC 13D) — 53KB
- 0001493152-24-038196.txt ( ) — 55KB
SIGNATURES
SIGNATURES After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information set forth in this Dated: September 26, 2024 STELLARS CAPITAL PRIVATE I LIMITED By: /s/ Mao Zhang Mao Zhang, Director